Compare weight loss treatments in Ireland
Five GLP-1 treatments are licensed in Ireland, from €149.99 to €554.95 a pack. Mounjaro produces the largest average weight reduction and costs the most. Wegovy is the cheapest weekly option carrying the correct weight management licence. Only treatments prescribed for type 2 diabetes reach State reimbursement.
Three things actually change your decision: what it costs across a year, whether it carries the licence you need, and whether you will keep taking it. Everything else is detail.
How the five weight loss injections differ, by what matters to you
Wegovy
~€1,820 a year. Weekly, correct licence for weight management, and roughly half what Mounjaro costs.
Mounjaro
~€3,607 a year. Dual receptor action, biggest average reduction in head-to-head data, highest price.
Saxenda
€149.99 to start. Generally the most reliable availability of the five, but daily dosing pushes the annual cost highest.
What each one really costs across a year
The pack price is misleading on its own. A cheap pack you buy every week costs more than an expensive one you buy every eight.
Saxenda is the clearest example. It has the lowest entry price of the five at €149.99, and the highest annual cost of the five at roughly €3,816, because it is injected daily rather than weekly.
Add €35 to €90 for each consultation and €60 to €100 for baseline bloods on top of every figure here. Full price index →
All five weight loss treatments side by side
| Mounjaro | Wegovy | Ozempic | Rybelsus | Saxenda | |
|---|---|---|---|---|---|
| Ingredient | Tirzepatide | Semaglutide | Semaglutide | Semaglutide | Liraglutide |
| Receptors | GLP-1 + GIP | GLP-1 | GLP-1 | GLP-1 | GLP-1 |
| Form | Injection | Injection | Injection | Tablet | Injection |
| Frequency | Weekly | Weekly | Weekly | Daily | Daily |
| Doses per month | ~4 | ~4 | ~4 | ~30 | ~30 |
| Licensed for | Diabetes, weight | Weight | Diabetes | Diabetes | Weight |
| Max dose | 15 mg | 2.4 mg | 1 mg | 14 mg | 3 mg |
| Titration | 20 weeks | 16 weeks | 8 weeks | 8 weeks | 5 weeks |
| Pack price | €554.95 | €279.95 | from €260 | from €198 | from €149.99 |
| Annual, approx | €3,607 | €1,820 | €3,380 | €3,120 | €3,816 |
| DPS, diabetes | Yes | N/A | Yes | Yes | N/A |
| DPS, weight loss | No | No | No | No | No |
| Availability | Variable | Variable | Variable | Good | Good |
Which produces the most weight loss?
In head-to-head trial data the order is tirzepatide, then semaglutide at 2.4 mg, then liraglutide. Mounjaro leads, Wegovy follows, Saxenda trails.
Two caveats worth holding onto. Averages hide enormous individual variation, and plenty of people do better on semaglutide than the average tirzepatide result. And trial participants receive structured dietary and activity support that most private patients never get, so real-world results are typically more modest across every treatment.
Dose matters more than brand. Ozempic and Wegovy are the same molecule. Wegovy outperforms Ozempic for weight loss because it reaches 2.4 mg where Ozempic stops at 1 mg, not because it is a different drug. The full explanation →
Daily or weekly dosing, and why it decides more than you think
Three of the five are weekly, two are daily. That sounds like a minor convenience question and it is not.
Adherence to daily dosing falls off faster than weekly in practice, across every therapeutic area where it has been measured. A treatment you stop taking does not work, and these medicines only work while they are being taken.
Rybelsus adds a further layer. The tablet must be taken on waking, on an empty stomach, with no more than half a glass of water, and nothing else for at least thirty minutes. If your mornings are unpredictable, that window becomes a daily obstacle rather than a routine.
Side effects: how they differ
The profile is broadly similar across the class, because they share a mechanism. Nausea, diarrhoea, constipation and reduced appetite, worst in the days after each dose increase.
What differs is the ramp. Saxenda titrates weekly across five weeks, which is the fastest of the five and the reason its first fortnight is often the hardest. Mounjaro steps up every four weeks across twenty, the slowest, which many people find gentler despite reaching a far higher dose.
Injection site reactions are more frequent with the daily treatments for the obvious reason: roughly thirty injections a month rather than four. What to expect and when to worry →
Availability in Ireland
Supply has been the constraint rather than licensing. Semaglutide and tirzepatide demand outpaced manufacturing across Europe, and Irish pharmacies have at times prioritised patients with type 2 diabetes when stock was short.
Saxenda and Rybelsus have generally been easier to obtain, partly because demand shifted towards the newer treatments. Ring ahead and ask your pharmacist to check wholesaler stock before the prescription is issued.
How the treatments differ for different circumstances
If you have type 2 diabetes
Ozempic, Mounjaro and Rybelsus are licensed for type 2 diabetes, and your prescriber decides which, if any, is appropriate. You may be able to register for the Drugs Payment Scheme. You can also check the Long Term Illness Scheme, which covers diabetes medicines with no means test and no charge at all.
If weight management is the goal
Wegovy has the weight management licence and is dosed weekly. Its annual medication cost is roughly half that of Mounjaro. Whether it is suitable is for your prescriber to decide.
If the largest average trial result matters to you
Mounjaro had the largest average result in trials and costs roughly €1,800 a year more than Wegovy. Mounjaro compared with Wegovy →
If you want to avoid injections
Rybelsus is the only oral option. It is licensed for diabetes rather than weight loss, and the timing rules are strict.
If availability is a concern
Saxenda has the lowest entry price and generally the most reliable availability. It is a daily injection, and its annual cost is the highest of the five.
None of this is a recommendation. Suitability depends on your medical history, current medication and factors a website cannot assess, including personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, and pregnancy. The prescriber decides. How to get a prescription →
Ask for pharmacy quotes and prescriber details
Tell us your county or city. We will send you pharmacy quotes near you and details of an Irish prescriber who can assess whether treatment is suitable. We do not recommend any particular medicine.
- Quotes from pharmacies near you, pharmacy by pharmacy
- An Irish specialist who can assess you and prescribe if suitable
- Whether your case is likely to qualify for State reimbursement
Comparing weight loss injections in Ireland: common questions
There is no single best. Mounjaro produced the largest average weight reduction in head-to-head trial data but costs the most. Wegovy is the cheapest weekly option with the correct weight management licence. Saxenda has the lowest entry price but the highest annual cost because it is daily. The right choice depends on budget, tolerance and what your prescriber judges appropriate.
Wegovy, at roughly €1,820 a year for medication at maintenance dosing. Saxenda has the lowest entry price at €149.99 but works out around €3,816 a year because it is injected daily rather than weekly.
Wegovy, Saxenda and Mounjaro carry a weight management licence. Ozempic and Rybelsus are licensed for type 2 diabetes only, so prescribing them for weight loss alone is off-label and many Irish GPs decline.
Yes, and it is done in practice. Switching within the same molecule, such as Ozempic to Wegovy, is generally more straightforward than moving between different molecules. Your prescriber decides the starting dose on the new treatment.
Only when prescribed for type 2 diabetes. Ozempic, Mounjaro and Rybelsus reach the cap on that indication. Wegovy and Saxenda never do, because weight management is their only licensed use and it is not a reimbursed indication in Ireland.
The profile is similar across the class because they share a mechanism. What differs is the ramp. Saxenda titrates weekly over five weeks, which some people find harder, while Mounjaro steps up every four weeks over twenty. Slower titration generally means gentler side effects.
Weight loss pills, drugs and injections in Ireland: what else exists
People search weight loss pills Ireland and weight loss drugs Ireland expecting a tablet alternative to injections. Within the GLP-1 class there is exactly one, Rybelsus, and it is oral semaglutide rather than a different drug.
Outside the class, older options are still prescribed in Ireland. Orlistat blocks fat absorption and is the one sold over the counter at low dose. Naltrexone with bupropion Ireland-wide is prescribed as Mysimba and works on appetite pathways in the brain rather than the gut. Both produce smaller average results than any GLP-1, which is why the newer drugs took the market.
Searching weight loss tablets Boots Ireland will mostly return over-the-counter orlistat. It is a licensed medicine and it works for some people, but it is not comparable to a GLP-1 and it is worth knowing that before you spend money on it.
More on comparing GLP-1 treatments in Ireland
Mounjaro vs Wegovy
Almost double the price. Whether the difference is worth it.
GuideOzempic vs Wegovy
Same molecule, opposite answers on licence and funding.
GuideWhat happens when you stop
Two thirds of lost weight returned within a year in the trial.
Weight loss injection prices in Ireland
Every current price for all five treatments, side by side.
GuideMounjaro in Ireland: cost and access
Tirzepatide pricing, titration and how to be prescribed it.
GuideSaxenda in Ireland: cost and access
The lowest entry price, and why the annual cost is the highest.
Yes. Rybelsus is an oral semaglutide tablet licensed in Ireland, and Mysimba and orlistat are also available on prescription. The injections produce larger average weight reduction in the published trials, but a tablet suits people who will not use a needle.